anmelden
FTSE 100
10.478,34
PKT
-18,78
PKT
-0,18
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu FTSE 100-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 10.04.24 | HSBC Neutral | JP Morgan Chase & Co. | |
| 09.04.24 | BP Outperform | RBC Capital Markets | |
| 09.04.24 | Rio Tinto Buy | Jefferies & Company Inc. | |
| 09.04.24 | BP Overweight | Barclays Capital | |
| 09.04.24 | HSBC Neutral | JP Morgan Chase & Co. | |
| 09.04.24 | BP Underweight | JP Morgan Chase & Co. | |
| 09.04.24 | HSBC Neutral | UBS AG | |
| 09.04.24 | BP Buy | UBS AG | |
| 09.04.24 | Diageo Hold | Jefferies & Company Inc. | |
| 09.04.24 | BP Buy | Jefferies & Company Inc. | |
| 09.04.24 | BP Underweight | JP Morgan Chase & Co. | |
| 08.04.24 | GSK Equal Weight | Barclays Capital | |
| 08.04.24 | AstraZeneca Overweight | Barclays Capital | |
| 08.04.24 | Unilever Overweight | Barclays Capital | |
| 05.04.24 | Shell (ex Royal Dutch Shell) Overweight | Barclays Capital | |
| 05.04.24 | AstraZeneca Sell | UBS AG | |
| 05.04.24 | National Grid Buy | UBS AG | |
| 05.04.24 | Shell (ex Royal Dutch Shell) Neutral | UBS AG | |
| 05.04.24 | Shell (ex Royal Dutch Shell) Outperform | RBC Capital Markets | |
| 05.04.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 05.04.24 | Shell (ex Royal Dutch Shell) Buy | Jefferies & Company Inc. | |
| 05.04.24 | BP Underweight | JP Morgan Chase & Co. | |
| 05.04.24 | Shell (ex Royal Dutch Shell) Overweight | JP Morgan Chase & Co. | |
| 04.04.24 | GSK Equal Weight | Barclays Capital | |
| 04.04.24 | Rio Tinto Overweight | Barclays Capital | |
| 04.04.24 | International Consolidated Airlines Outperform | Bernstein Research | |
| 04.04.24 | BP Buy | UBS AG | |
| 04.04.24 | Rio Tinto Buy | Deutsche Bank AG | |
| 04.04.24 | HSBC Sector Perform | RBC Capital Markets | |
| 04.04.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 04.04.24 | BP Outperform | RBC Capital Markets | |
| 04.04.24 | Shell (ex Royal Dutch Shell) Outperform | RBC Capital Markets | |
| 03.04.24 | GSK Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 03.04.24 | Shell (ex Royal Dutch Shell) Buy | Jefferies & Company Inc. | |
| 03.04.24 | BP Buy | Jefferies & Company Inc. | |
| 03.04.24 | Vodafone Group Underperform | Bernstein Research | |
| 02.04.24 | Unilever Overweight | Barclays Capital | |
| 02.04.24 | Barclays Buy | Jefferies & Company Inc. | |
| 28.03.24 | Shell (ex Royal Dutch Shell) Outperform | RBC Capital Markets | |
| 28.03.24 | AstraZeneca Sell | Deutsche Bank AG |
* Die angezeigten Realtime Kurse sind indikativ und nicht die offiziellen Börsenkurse. Die Kursdaten können eventuell vom tatsächlichen Marktpreis abweichen.